Hydrochlorothiazide/Dihydralazine Sulfate/Promethazine Hydrochloride/Rutin/Chloroquine Phosphate/Potassium Chloride/Vitamin B1/Vitamin B6/Reserpine/Magnesium Trisilicate

氢氯噻嗪/硫酸双肼屈嗪/盐酸异丙嗪/芦丁/磷酸氯喹/氯化钾/维生素B1/维生素B6/利血平/三硅酸镁

Report date: 2023/02/21 20:00:25

Base Information

Drug NameHydrochlorothiazide/Dihydralazine Sulfate/Promethazine Hydrochloride/Rutin/Chloroquine Phosphate/Potassium Chloride/Vitamin B1/Vitamin B6/Reserpine/Magnesium Trisilicate
Drug Alias Name复方三嗪芦丁片
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThiazide-sensitive sodium-chloride cotransporter inhibitorsHistamine H1 receptor antagonistsVitamin B1 supplements +[4] 
TargetsThiazide-sensitive sodium-chloride cotransporterHistamine H1 receptorSynaptic vesicular amine transporter
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes HydrochlorothiazideDihydralazine SulfatePromethazine Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesChifeng Weikang Biochemical Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A